about
Propagation of prions causing synucleinopathies in cultured cellsTau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective StrategiesImaging Multimodalities for Dissecting Alzheimer's Disease: Advanced Technologies of Positron Emission Tomography and Fluorescence ImagingBlood biomarkers for brain injury: What are we measuring?The preclinical phase of the pathological process underlying sporadic Alzheimer's diseasePropagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.Glial contributions to neurodegeneration in tauopathies.Immunological memory to hyperphosphorylated tau in asymptomatic individuals.Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potencyCharacterization of tau prion seeding activity and strains from formaldehyde-fixed tissue.Tau aggregation and its interplay with amyloid-β.Passive Immunization in JNPL3 Transgenic Mice Using an Array of Phospho-Tau Specific Antibodies.Activation of necroptosis in multiple sclerosisProgression of Seed-Induced Aβ Deposition within the Limbic ConnectomeEarly Generation of New PrPSc on Blood Vessels after Brain Microinjection of Scrapie in MiceNeuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer's disease brain.Transport of cargo from periphery to brain by circulating monocytes.Characterization of TauC3 antibody and demonstration of its potential to block tau propagationRemoving endogenous tau does not prevent tau propagation yet reduces its neurotoxicityDetecting tau in serum of transgenic animal models after tau immunotherapy treatment.Sensitive Detection of Proteopathic Seeding Activity with FRET Flow Cytometryα-Synuclein and huntingtin exon 1 amyloid fibrils bind laterally to the cellular membrane.Extracellular Vesicles Isolated from the Brains of rTg4510 Mice Seed Tau Protein Aggregation in a Threshold-dependent Manner.Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43.Evidence of Tau Hyperphosphorylation and Dystrophic Microglia in the Common Marmoset.Prions and Protein Assemblies that Convey Biological Information in Health and Disease.Hierarchical Distribution of the Tau Cytoskeletal Pathology in the Thalamus of Alzheimer's Disease Patients.A mouse Model of Focal Vascular Injury Induces Astrocyte Reactivity, Tau Oligomers, and Aberrant Behavior.Intracellular and extracellular microtubule associated protein tau as a therapeutic target in Alzheimer disease and other tauopathies.Amyloid-β(1-42) Aggregation Initiates Its Cellular Uptake and Cytotoxicity.Enhanced Tau Aggregation in the Presence of Amyloid β.Monoaminergic neuropathology in Alzheimer's disease.Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy.Cellular Models for the Study of Prions.Molecular Genetics of Neurodegenerative Dementias.Therapeutic Strategies for Restoring Tau Homeostasis.Interactions of pathological proteins in neurodegenerative diseases.Molecular Chaperone Accumulation in Cancer and Decrease in Alzheimer's Disease: The Potential Roles of HSF1.
P2860
Q26269822-4797E705-29DE-44A3-99ED-24E3C9A6505CQ26769957-8AC4E082-F8B1-40E3-8085-291B3E4CDCDBQ26770766-425204B3-2DA9-46F2-A1A1-2F382BB37CA0Q28067275-FB532911-A4FB-4840-801B-B00A02EEF7B5Q28083428-676DAEAB-D779-4D5F-B226-6581E255F759Q31024674-D3193D72-6493-4C74-9191-6B8BDAFC993DQ32173558-63963DE3-362F-4E59-A229-C7C59F707072Q33559360-77FE690A-CAC9-46E0-92BB-7772E564B09AQ33640390-5E2569D0-7E88-420F-87D2-6A448DD7F379Q33771643-8B012EAE-060F-4B68-9EC9-542BFCE93B6DQ35008256-32E77534-761E-4125-AB5F-20E5025B5E83Q35745135-F8ED87F9-5E9B-479E-B738-EECD22E4167BQ35828763-E8D70EBA-6DC4-425C-B8AC-AAD6BEA4A598Q35931728-EC632AAA-82DE-46C6-953B-B8EBC939FC4EQ36143652-28C6D19D-1E19-4CE7-B7D5-49286EF0E859Q36169754-AB7B0099-D944-4402-9E39-830BEF7A94C2Q36274153-1009B9EA-5864-44B1-AA1E-60D01733C27BQ36377638-517C3BD5-0C8B-4B48-8DA4-56D2F8E955B5Q36394952-9A9C8727-2661-41C4-A477-A64D85863E51Q36395623-145CFB3E-8010-4A65-8F3C-E4410465AAFEQ36408405-BB140738-2143-4496-85A8-15B7FF776214Q36499643-244F404C-2CF3-4976-AED1-D928993992EEQ37066447-0FB49DA2-D801-4BCC-A0BA-35D6E49A8D06Q37297626-30BC726E-EB8D-438C-B201-915AFD07C933Q37451385-45139097-C0BE-4A71-A159-462C24966AA3Q37525481-9259820F-2BA9-423E-9A7E-3D0A80F3415AQ38336025-0927DEE9-6C6B-45E2-B9D0-06F32F52DF22Q38620932-92976E7C-416F-459C-9332-EC8F7C225DCAQ38652516-36EA7035-162F-42A6-A068-75F5D68DCA74Q38664605-2CE2A7AB-5852-4F10-9CD9-A004FCB32D53Q38755870-6202DEB1-14A0-4D79-BA23-F06F61144815Q38788206-182F27C6-26B3-4A77-8EB3-2A596AE264DDQ38809649-4FBA3FCE-F94F-4230-A535-FF00E9EF3E0FQ38942540-7D4B1B8F-E9E7-4FB4-9F2A-FC7DE36814E1Q38998886-191ED7EF-4155-4EC1-9AC7-7FA617C3CD2FQ38999133-DF9F5686-83C1-45FC-86A9-B7537CA3306BQ39035458-F8674A84-19FB-42C8-B248-0AACD324F788Q39118898-C67B5DEA-C5EB-4689-9BF9-28F93FD5994CQ39236779-BEEF820E-AFE2-420B-A0C2-E36E71ADBE63Q39292455-F8115944-DFE9-40B4-B90A-266CAD1B2878
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Proteopathic tau seeding predicts tauopathy in vivo.
@ast
Proteopathic tau seeding predicts tauopathy in vivo.
@en
Proteopathic tau seeding predicts tauopathy in vivo.
@nl
type
label
Proteopathic tau seeding predicts tauopathy in vivo.
@ast
Proteopathic tau seeding predicts tauopathy in vivo.
@en
Proteopathic tau seeding predicts tauopathy in vivo.
@nl
prefLabel
Proteopathic tau seeding predicts tauopathy in vivo.
@ast
Proteopathic tau seeding predicts tauopathy in vivo.
@en
Proteopathic tau seeding predicts tauopathy in vivo.
@nl
P2093
P2860
P356
P1476
Proteopathic tau seeding predicts tauopathy in vivo
@en
P2093
David M Holtzman
Hilda Mirbaha
Jennifer L Furman
Larisa Belaygorod
Marc I Diamond
Nigel J Cairns
Tritia R Yamasaki
William C Eades
P2860
P304
P356
10.1073/PNAS.1411649111
P407
P577
2014-09-26T00:00:00Z